- Home
- NVOS vs NURO Comparison
NVOS vs NURO Comparison
Compare NVOS & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVOS
- NURO
- Stock Information
- Founded
- NVOS 2000
- NURO 1996
- Country
- NVOS United States
- NURO United States
- Employees
- NVOS N/A
- NURO N/A
- Industry
- NVOS Assisted Living Services
- NURO Medical/Dental Instruments
- Sector
- NVOS Health Care
- NURO Health Care
- Exchange
- NVOS Nasdaq
- NURO Nasdaq
- Market Cap
- NVOS 5.6M
- NURO 8.2M
- IPO Year
- NVOS 2017
- NURO N/A
- Fundamental
- Price
- NVOS $0.23
- NURO $4.42
- Analyst Decision
- NVOS
- NURO
- Analyst Count
- NVOS 0
- NURO 0
- Target Price
- NVOS N/A
- NURO N/A
- AVG Volume (30 Days)
- NVOS 326.8K
- NURO 14.4K
- Earning Date
- NVOS 12-12-2024
- NURO 11-01-2024
- Dividend Yield
- NVOS N/A
- NURO N/A
- EPS Growth
- NVOS N/A
- NURO N/A
- EPS
- NVOS N/A
- NURO N/A
- Revenue
- NVOS $13,516,958.00
- NURO $4,383,614.00
- Revenue This Year
- NVOS N/A
- NURO N/A
- Revenue Next Year
- NVOS N/A
- NURO N/A
- P/E Ratio
- NVOS N/A
- NURO N/A
- Revenue Growth
- NVOS 1102.98
- NURO N/A
- 52 Week Low
- NVOS $0.20
- NURO $2.66
- 52 Week High
- NVOS $3.45
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- NVOS 38.13
- NURO 65.06
- Support Level
- NVOS $0.20
- NURO $3.96
- Resistance Level
- NVOS $0.31
- NURO $4.69
- Average True Range (ATR)
- NVOS 0.03
- NURO 0.22
- MACD
- NVOS 0.00
- NURO 0.04
- Stochastic Oscillator
- NVOS 27.18
- NURO 82.35
About NVOS Novo Integrated Sciences Inc.
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.